Literature DB >> 29898477

Prevalence of syringomyelia in clinically unaffected Cavalier King Charles Spaniels in Germany (2006-2016).

Sabine Schulze, Miriam Refai, Martin Deutschland, Klaus Failing, Martin Schmidt.   

Abstract

OBJECTIVE: The aim of the study was to investigate the prevalence of syringomyelia in clinically unaffected Cavalier King Charles Spaniels (CKCS) in Germany.
MATERIAL AND METHODS: From 2006 to 2016 a total of 339 asymptomatic CKCSs from all over Germany were included. Age ranged from 3 months to 11 years (mean 3.72 years ± 2.17 years). T1- and T2-weighted magnetic resonance images of the head and cervical spine were obtained.
RESULTS: Overall, 163 out of 339 (48.1 %) CKCSs showed evidence of syringomyelia. The results (odds ratio of 1.27 per year; p < 0.0001) corroborate the findings of other studies, in which the risk of developing syringomyelia increases with age. CONCLUSION AND CLINICAL RELEVANCE: In conclusion, around half of the dogs within the German CKCS population are affected by syringomyelia. The prevalence of syringomyelia of the German CKCS population is similar to that of the British CKCS population, which is subjected to breeding strategies on the basis of magnetic resonance imaging investigations. Schattauer GmbH.

Entities:  

Mesh:

Year:  2018        PMID: 29898477     DOI: 10.15654/TPK-170725

Source DB:  PubMed          Journal:  Tierarztl Prax Ausg K Kleintiere Heimtiere        ISSN: 1434-1239            Impact factor:   0.596


  2 in total

Review 1.  Clinical Application of Diagnostic Imaging of Chiari-Like Malformation and Syringomyelia.

Authors:  Clare Rusbridge; Felicity Stringer; Susan P Knowler
Journal:  Front Vet Sci       Date:  2018-11-28

2.  Pilot study of head conformation changes over time in the Cavalier King Charles spaniel breed.

Authors:  Susan Penelope Knowler; Lena Gillstedt; Thomas J Mitchell; Jelena Jovanovik; Holger Andreas Volk; Clare Rusbridge
Journal:  Vet Rec       Date:  2019-01-11       Impact factor: 2.695

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.